Insider trades
Stock that executives, directors and 10% owners bought and sold on the open market, from the Form 4s they file with the SEC within two business days. Grants, option exercises and shares sold to cover taxes are left out.
- $1.9B bought by 478 insiders at 311 companies
- $8.7B sold by 573 insiders outside a trading plan
- $4.4B sold by 900 insiders under 10b5-1 plans
- 10 companies where two or more insiders bought (30 days)
Biggest buys
Past month · by insider, all their filings added up
-
LENLennar CorporationBerkshire Hathaway Inc.10% owner · +1 joint filer$595M
-
RSGRepublic Services, Inc.Cascade Investment, L.l.c.10% owner · +1 joint filer$289M
-
CRBGCorebridge Financial Inc.Life Insurance Co Nippon10% owner$158M
-
KODKodiak Sciences IncBaker Bros. Advisors LPDirector · +5 joint filers$157M
-
GPIGroup 1 Automotive, Inc.Conifer Management, L.L.C.10% owner$138M
-
UUUUniversal Safety Products, Inc.Milton C Ault IIIDirector$92.5M
-
GMEGameStop CorporationRyan CohenCEO$74.4M
-
FTKFlotek Industries, Inc.Matthew WilksDirector$34.3M
-
GRABGrab Holdings LimitedAnthony Ping Yeow TanCEO$29.9M
-
GSATGlobalstar, Inc.James Monroe IIIDirector$29.8M
Biggest sales
Past month · by insider, all their filings added up · planned sales marked
-
FANGDiamondback Energy, Inc.SGF FANG Holdings, LP10% owner · +1 joint filer$3.7B
-
MDLNMedline Inc.GIC Private Ltd10% owner · +2 joint filers$722M
-
INGMIngram Micro Holding CorporationPlatinum Equity, LLC10% owner · +9 joint filers$410M
-
IHTInnSuites Hospitality TrustMarc E BergEVP & Secretary/Treasurer$361M
-
NVDANvidia Corporation ComMark A StevensDirector$300M
-
AVGOBroadcom Inc.Henry SamueliDirector$250M
-
CHYMChime Financial, Inc.DST Global Advisors Ltd10% owner · +9 joint filers$237M
-
UMCUnited Microelectronics CorporationChitung LiuCFO$229M
-
LFSTLifeStance Health Group, Inc.Tpg Gp A, LLC10% owner · +2 joint filers$226M
-
THTarget Hospitality Corp.TDR Capital II Investments LP10% owner · +9 joint filers$202M
Cluster buying
Companies where two or more insiders bought on the open market in the last 30 days · most buyers first
-
Reuben S Leibowitz Director, Larry C Glasscock Director, Daniel C. Smith Director, Gary M Rodkin Director, +7 more
-
Alexandros Pappas Insider, Raffaele Zagari Director, Symeon Spyrou CFO, Nikolaos Reskos COO, +3 more
-
Daniel L Florness Director, Srilata Zaheer Director, Charles T Lauber Director, Trangsrud Teresa J Rasmussen Director, +3 more
-
Christopher J Abate CEO, Dashiell I Robinson President, Greg H Kubicek Director, Brooke Carillo CFO, +2 more
-
Matthew G De Soto Director, Albert J. Evans Director, Rory G Ritrievi CEO, Kimberly J Brumbaugh Director, +2 more
-
Tricor PMT25 Holdings Inc. 10% owner, H Sanford Riley Chair, Nicholas Peters Director, Marc Sheinbaum Director, +1 more
-
Avenue RP Opportunities Fund, L.P. 10% owner, Par Chadha Director, Avenue Global Opportunities Master Fund LP 10% owner, Andrej Jonovic CEO, +1 more
-
Thomas Jon Hammond Director, Sandip I Patel CFO, John Martin Schaible Chair, David Craig Ridenhour President, +1 more
-
John B Williamson III Director, Robert B Johnston Director, Paul W Nester CEO, Lawrence T. Oliver Senior VP and Secretary, +1 more
-
Kourosh Nasser Zamanizadeh Director, Bessie Ross Wills Director, Nicole Sherman CEO, Stacey Graham Director, +1 more
All insider trades
Newest filings first · one row per filing · every open-market buy and sale
-
Christopher L Jensen EVP, Chief People OfficerNXPINXP Semiconductors N.V.Planned sale$805K 3,355 shares at $240.00 92% of stakeTraded Oct 1 Filed Oct 5
-
Feng Zhao President of GarenaSESea LimitedPlanned sale$3.8M 40,000 shares at $95.02 30% of stakeTraded Oct 1 Filed Oct 5
-
Yanjun Wang CCO and GCSESea LimitedPlanned sale$190K 2,000 shares at $95.10 2.2% of stakeTraded Oct 1–2 Filed Oct 5
-
Chan Henry Lee SVP, General CounselONCBeOne Medicines Ltd.Planned sale$418K 1,115 shares at $375.00 100% of stakeTraded Sep 30 Filed Oct 2
-
Steven Leonard Chapman CEONTRANatera, Inc.Planned sale$526K 1,273 shares at $413.31 1.3% of stakeTraded Oct 1 Filed Oct 2
-
Solomon Moshkevich President, ClinicaldiagnosticsNTRANatera, Inc.Planned sale$1.2M 3,000 shares at $414.22 2.7% of stakeTraded Oct 1 Filed Oct 2
-
Michael Sentonas PresidentCRWDCrowdStrike Holdings, Inc.Planned sale$64.2M 241,944 shares at $265.45 16% of stakeTraded Sep 30 Filed Oct 2
-
Heidy King-Jones See RemarksSYRESpyre Therapeutics, Inc.Planned sale$2.6M 28,933 shares at $91.03 91% of stakeTraded Oct 1 Filed Oct 2
-
Cameron Turtle CEOSYRESpyre Therapeutics, Inc.Planned sale$1.4M 15,000 shares at $92.01 2.7% of stakeTraded Oct 1 Filed Oct 2
-
Scott L Burrows CFOSYRESpyre Therapeutics, Inc.Planned sale$2.3M 25,000 shares at $90.47 24% of stakeTraded Sep 30–Oct 1 Filed Oct 2
-
James David Johnston Executive VP, GC, CCO and SecySMCSummit Midstream CorporationPlanned sale$79K 2,600 shares at $30.51 3.5% of stakeTraded Oct 1 Filed Oct 2
-
Johannes Jacob Pieter Kastelein Chief Scientific OfficerNAMSNewAmsterdam Pharma Company N.V.Planned sale$1.3M 50,246 shares at $25.03 42% of stakeTraded Sep 30 Filed Oct 2
-
Lisa Gimbel Chief Accounting OfficerPUBMPubMatic, Inc.Planned sale$9,495 500 shares at $18.99 3% of stakeTraded Oct 1 Filed Oct 2
-
Life Insurance Co Nippon 10% ownerCRBGCorebridge Financial Inc.Buy$11.7M 348,215 shares at $33.65 +0.3% to stakeTraded Sep 30 Filed Oct 2
-
Brett Alan Cope CEOPOWLPowell Industries, Inc.Sale$901K 4,799 shares at $187.67 0.9% of stakeTraded Sep 30 Filed Oct 2
-
Yi-Chien Lin 10% ownerXAIRBeyond Air, Inc.Buy$57K 20,393 shares at $2.77 +16% to stakeTraded Sep 29–Oct 1 Filed Oct 2
-
Chris Riccardi DirectorWVVIWillamette Valley Vineyards, Inc.Buy$4,718 2,617 shares at $1.80 +0.5% to stakeTraded Sep 25–Oct 1 Filed Oct 2
-
Gregory C. Hamm CFOLMNRLimoneira CoPlanned sale$12K 1,000 shares at $11.91 1.2% of stakeTraded Oct 1 Filed Oct 2
-
Jim Wassil COOPCVXVaxcyte, Inc.Planned sale$128K 2,250 shares at $56.67 1.5% of stakeTraded Oct 1 Filed Oct 2
-
Ryan McInerney CEOVVisa Inc-Class A ShrsPlanned sale$2.1M 5,875 shares at $358.81 28% of stakeTraded Oct 1 Filed Oct 2
-
Jesse K Bray Pres & CEO, Rocket MortgageRKTRktPlanned sale$1.6M 132,700 shares at $12.01 1.7% of stakeTraded Oct 1 Filed Oct 2
-
Scott Jeffrey Klum 10% ownerROCRank One Computing CorporationSale$4.1M 1,200,000 shares at $3.42 41% of stakeTraded Sep 30 Filed Oct 2
-
Opaleye Management Inc. 10% ownerACOGAlpha Cognition Inc.Buy$166K 19,050 shares at $8.69 +0.6% to stakeTraded Oct 1 Filed Oct 2
-
Robert Fauber CEOMCOMoody's CorporationPlanned sale$420K 923 shares at $455.00 1.8% of stakeTraded Oct 1 Filed Oct 2
-
Bernard Shek Chief Legal Officer and SectySNDKSandisk Corp.Planned sale$1M 600 shares at $1,734.94 2.3% of stakeTraded Oct 1 Filed Oct 2
-
Michael L Speiser DirectorSNOWSnowflake Inc.Planned sale$17.5M 50,741 shares at $344.00Traded Oct 2 Filed Oct 2
-
Michael S Williams CEOMTUSMetallus Inc.Planned sale$251K 12,570 shares at $20.01 1.7% of stakeTraded Oct 2 Filed Oct 2
-
Christian Kleinerman EVP, Product ManagementSNOWSnowflake Inc.Planned sale$5.1M 15,000 shares at $341.57 4.6% of stakeTraded Oct 1 Filed Oct 2
-
Paula Hansen Chief Revenue OfficerDOCUDocuSign, Inc.Planned sale$227K 3,300 shares at $68.81 3% of stakeTraded Oct 1 Filed Oct 2
-
James P Shaughnessy Chief Legal OfficerDOCUDocuSign, Inc.Planned sale$826K 12,000 shares at $68.80 19% of stakeTraded Oct 1 Filed Oct 2
-
Allan C. Thygesen CEODOCUDocuSign, Inc.Planned sale$1.8M 26,250 shares at $69.29 14% of stakeTraded Oct 1 Filed Oct 2
-
Mary Agnes Wilderotter DirectorDOCUDocuSign, Inc.Planned sale$69K 1,000 shares at $68.80 31% of stakeTraded Oct 1 Filed Oct 2
-
Lawrence Otto Klein CEOORKAOruka Therapeutics, Inc.Planned sale$2.1M 25,000 shares at $83.62 2.6% of stakeTraded Oct 1 Filed Oct 2
-
Joseph F Hanna DirectorMGRCMcGrath RentCorpPlanned sale$863K 7,500 shares at $115.04 4.9% of stakeTraded Oct 1 Filed Oct 2
-
Foundation Fighting Blindness Retinal Degeneration Fund Director · +1 joint filerIRDOpus Genetics, Inc.Sale$2.8M 556,000 shares at $4.96 15% of stakeTraded Sep 30 Filed Oct 2
-
Randolph Altschuler DirectorXMTRXometry, Inc.Planned sale$1M 10,000 shares at $104.04 1.8% of stakeTraded Oct 1 Filed Oct 2
-
John Daunt EVP, Chief Commercial OfficerLQDTLiquidity Services, Inc.Planned sale$31K 715 shares at $42.75 1.8% of stakeTraded Oct 1 Filed Oct 2
-
Richard N. Frommer DirectorPROPPrairie Operating Co.Buy$13K 28,000 shares at $0.4500 +9.2% to stakeTraded Sep 3 Filed Oct 2
-
Frederick G Thiel CEOMARAMARA Holdings, Inc.Planned sale$309K 27,505 shares at $11.22 0.6% of stakeTraded Oct 1 Filed Oct 2
-
Christopher Ryan Schadel Chief Marketing OfficerZSQRZ Squared Inc.Buy$3,920 1,000 shares at $3.92 +41% to stakeTraded Aug 18 Filed Oct 2
-
Francis S Soistman Jr. DirectorEHTHeHealth, Inc.Planned sale$28K 40,612 shares at $0.6900 4% of stakeTraded Oct 1–2 Filed Oct 2
-
Shannon O'Donnell Senior Vice PresidentAUBNAuburn National Bancorporation, Inc.Buy$743 27 shares at $27.53 +1.4% to stakeTraded Sep 30 Filed Oct 2
-
David E Housel DirectorAUBNAuburn National Bancorporation, Inc.Buy$1,402 51 shares at $27.49 +0.5% to stakeTraded Sep 30 Filed Oct 2
-
Spenser Skates CEOAMPLAmplitude, Inc.Planned sale$71K 4,913 shares at $14.45 100% of stakeTraded Sep 30–Oct 1 Filed Oct 2
-
J Tutt Barrett DirectorAUBNAuburn National Bancorporation, Inc.Buy$2,007 73 shares at $27.50 +0.8% to stakeTraded Sep 30 Filed Oct 2
-
Patricia Y Grech SVP, Chief Accounting OfficerQCOMQUALCOMM IncorporatedPlanned sale$18K 98 shares at $186.55 100% of stakeTraded Oct 2 Filed Oct 2
-
William F Ham Jr. DirectorAUBNAuburn National Bancorporation, Inc.Buy$1,288 47 shares at $27.41 +0.9% to stakeTraded Sep 30 Filed Oct 2
-
George Kurtz CEOCRWDCrowdStrike Holdings, Inc.Planned sale$5.3M 20,000 shares at $265.46 0.3% of stakeTraded Sep 30–Oct 1 Filed Oct 2
-
Todd C. Skinner President, InternationalTRUTransUnionPlanned sale$62K 1,000 shares at $62.29 1.8% of stakeTraded Oct 1 Filed Oct 2
-
Mohamed Abdelsadek EVP, Chief Global SolutionsTRUTransUnionPlanned sale$16K 250 shares at $62.29 0.5% of stakeTraded Oct 1 Filed Oct 2
About this data
- Officers, directors and anyone owning more than 10% of a company must report a trade in its stock on a Form 4 within two business days. We read each filing from SEC EDGAR and link to it on every row.
- Only open-market purchases and sales of common stock count here. Stock grants, option exercises, gifts and shares withheld or sold to pay taxes on vesting awards are not decisions to buy or sell, so they are left out.
- A planned sale was made under a Rule 10b5-1 trading plan, which the insider set up months in advance. Many executives sell this way on a schedule, so a planned sale says less than one made on the day.
- Values are shares times the price reported. When a filing amends an earlier one, the amended trades replace the originals. Related owners (a fund and its manager) who report the same trade separately are shown once.
- We cover the 4,792 US companies on our earnings calendar, with a year of history. The superinvestor notes count the featured 13F managers who added or cut the stock in their latest quarter.